HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael C Jensen Selected Research

hygromycin A

9/2010Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
2/2005Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael C Jensen Research Topics

Disease

63Neoplasms (Cancer)
01/2022 - 02/2003
15Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2004
13Lymphoma (Lymphomas)
01/2020 - 04/2004
12Glioma (Gliomas)
12/2019 - 12/2004
8Neuroblastoma
01/2020 - 06/2004
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 02/2003
6Leukemia
01/2022 - 02/2003
3Residual Neoplasm
12/2019 - 02/2003
3B-Cell Lymphoma (Lymphoma, B Cell)
10/2019 - 09/2008
2Medulloblastoma
01/2021 - 10/2007
2Melanoma (Melanoma, Malignant)
10/2020 - 09/2007
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 10/2013
2Encephalitis (Encephalitis, Rasmussen)
01/2018 - 09/2015
2Brain Neoplasms (Brain Tumor)
07/2014 - 01/2014
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2010 - 09/2008
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2010 - 04/2004
2Infections
04/2009 - 01/2008
1Necrosis
01/2022
1Sarcoma (Soft Tissue Sarcoma)
01/2022
1Carcinogenesis
01/2021
1B-Cell Leukemia (Leukemia, B Cell)
01/2020
1Retinal Detachment (Retinal Detachments)
01/2020
1Teratoma (Teratoid Tumor)
12/2019
1Neuroectodermal Tumors (Neuroectodermal Tumor)
09/2019
1Retinoblastoma (Glioblastoma, Retinal)
09/2019
1cell-associated neurotoxicity
01/2019
1Lymphopenia (Lymphocytopenia)
01/2019
1Delirium
01/2019
1Osteosarcoma (Osteogenic Sarcoma)
01/2019
1Cytokine Release Syndrome
01/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
01/2016
1Ascites
01/2016

Drug/Important Bio-Agent (IBA)

45Chimeric Antigen ReceptorsIBA
01/2022 - 12/2004
23AntigensIBA
03/2021 - 02/2005
14CytokinesIBA
01/2020 - 06/2004
7Interleukin-13IBA
09/2015 - 12/2004
5Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2005
5EpitopesIBA
12/2019 - 12/2004
4Monoclonal AntibodiesIBA
01/2017 - 11/2010
4CD19-specific chimeric antigen receptorIBA
11/2016 - 07/2007
3AntibodiesIBA
10/2020 - 04/2004
3Cetuximab (Erbitux)FDA Link
12/2019 - 08/2011
3Interleukin-2 (IL2)IBA
12/2019 - 09/2003
3Neoplasm Antigens (Tumor Antigens)IBA
12/2019 - 01/2014
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2016 - 12/2004
3HLA Antigens (Human Leukocyte Antigens)IBA
04/2015 - 02/2005
3IL13-zetakineIBA
01/2014 - 12/2004
3Interleukin-13 Receptor alpha2 SubunitIBA
01/2014 - 12/2004
2Pharmaceutical PreparationsIBA
01/2022 - 11/2010
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
03/2021 - 01/2016
2Peptides (Polypeptides)IBA
01/2021 - 12/2019
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2020 - 12/2019
2ChemokinesIBA
10/2020 - 09/2007
2LigandsIBA
01/2019 - 01/2014
2Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
12/2016 - 01/2012
2Rituximab (Mabthera)FDA Link
01/2016 - 04/2004
2Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
06/2013 - 11/2010
2hygromycin AIBA
09/2010 - 02/2005
2Thymidine KinaseIBA
09/2010 - 01/2009
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2009 - 02/2003
2Firefly LuciferasesIBA
09/2007 - 02/2005
1PI103IBA
01/2022
1SteroidsIBA
01/2022
1aldesleukin (Proleukin)FDA Link
01/2022
1IntegrinsIBA
01/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1Interferon-gamma (Interferon, gamma)IBA
10/2020
1Interleukin-12 (IL 12)IBA
10/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1epidermal growth factor receptor VIIIIBA
12/2019
1Granzymes (Granzyme)IBA
12/2019
1Designed Ankyrin Repeat ProteinsIBA
12/2019
1Epithelial Cell Adhesion MoleculeIBA
12/2019
1tocilizumab (atlizumab)FDA Link
12/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2019
1Fluorescein (Funduscein)FDA LinkGeneric
01/2019
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2019
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1isothiocyanic acidIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Immunoglobulin G (IgG)IBA
11/2016
1Cell Adhesion MoleculesIBA
01/2016
1VaccinesIBA
07/2015
1Protein Subunit VaccinesIBA
07/2015
1Fc Receptors (Fc Receptor)IBA
02/2015
1matrigelIBA
07/2014
1ChitosanIBA
07/2014
1HydrogelsIBA
07/2014
1Ethylene Glycol (Monoethylene Glycol)IBA
07/2014

Therapy/Procedure

34Therapeutics
01/2022 - 06/2004
18Immunotherapy
01/2022 - 04/2004
7Drug Therapy (Chemotherapy)
09/2019 - 12/2009
4Hematopoietic Stem Cell Transplantation
01/2016 - 02/2003
1Cell Transplantation
01/2022
1Catheters
01/2021
1Blood Component Removal (Apheresis)
01/2019
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2019